You might have noticed that sex feels different now, or that everyday discomfort has crept in at the most ordinary moments: sitting at your desk, going for a walk, or just getting through the day. Vaginal dryness after menopause is one of the most common symptoms women experience in midlife, yet it is also one of the least talked about. Many women assume it is simply something to tolerate. It is not.
The discomfort is real, the causes are well understood, and there are treatments with strong evidence behind them. What follows is a plain, honest look at what is happening in your body and what you can actually do about it.
What Is Actually Happening in Your Body
Estrogen does a lot of quiet, unsung work in vaginal tissue. It keeps the walls of the vagina thick, elastic, and well-lubricated by maintaining blood flow and stimulating natural moisture. When estrogen levels fall sharply after menopause, the tissue thins, the pH rises, and moisture production drops significantly. Blood flow to the area decreases too, which affects sensation and healing.
Clinicians now use the term genitourinary syndrome of menopause, or GSM, to describe this broader picture. GSM encompasses vaginal dryness, but also burning, itching, painful intercourse, increased urinary urgency, and recurrent urinary tract infections. These symptoms often appear together because the urinary tract and vaginal tissue share the same estrogen receptors. Unlike hot flashes, which frequently resolve on their own over time, GSM tends to worsen without treatment.
Why Women Often Go Without Treatment
A significant number of women with GSM symptoms never bring them up with a clinician. Some feel embarrassed. Others have heard that these changes are simply part of aging and assume nothing can be done. A few have had providers brush off the concern or offer only a generic lubricant recommendation without discussing longer-term options.
There is also confusion about safety. After headlines about hormone therapy in the early 2000s, many women became cautious about anything hormone-related. The data has shifted considerably since then, and the medical conversation has changed, but the cultural hesitation has not fully caught up. The result is that many women are living with significant, quality-of-life-affecting symptoms when effective, well-studied treatments exist.
Vaginal dryness is not a cosmetic inconvenience. For many women in midlife, it quietly reshapes intimacy, physical activity, and daily comfort in ways that deserve direct clinical attention.
Treatment Options, From Least to Most Systemic
Treatment decisions depend on the severity of your symptoms, your overall health picture, and your personal preferences. There is a genuine spectrum here, not a single right answer. Below is a realistic look at what each tier offers.
Over-the-Counter Moisturizers and Lubricants
Non-hormonal vaginal moisturizers (used regularly, not just during sex) and lubricants (used during intercourse) are a reasonable starting point for mild symptoms. Products containing hyaluronic acid or polycarbophil can reduce daily dryness when used consistently. They do not treat the underlying tissue changes, but they can reduce friction and discomfort meaningfully. If your symptoms are mild and infrequent, this tier is worth trying first.
The limitation is that they work on the surface. For women with moderate to severe symptoms, or those whose discomfort is interfering with sex, sleep, or daily movement, moisturizers and lubricants alone tend to be insufficient.
Local (Topical) Estrogen Therapy
Low-dose vaginal estrogen is the most well-studied treatment for GSM and is considered first-line by most menopause specialists. It comes in several forms: a cream applied with an applicator, a small dissolvable tablet inserted vaginally, a soft flexible ring replaced every three months, or a newer suppository option. All of these deliver estrogen directly to vaginal tissue with minimal absorption into the bloodstream.
Because the dose is very low and absorption is limited, local estrogen is considered safe for most women, including many who cannot take systemic hormone therapy. The North American Menopause Society notes that local estrogen does not appear to carry the same risks associated with oral systemic hormones. Most women notice improvement in dryness, elasticity, and discomfort within four to twelve weeks of consistent use, with continued improvement over several months.
Ospemifene (an Oral Non-Estrogen Option)
For women who prefer not to use anything vaginally, ospemifene is an oral medication that acts selectively on vaginal estrogen receptors. It is approved specifically for dyspareunia (painful intercourse) due to GSM and has solid clinical evidence behind it. It is not appropriate for all women, particularly those with a history of certain hormone-sensitive conditions, so a physician review of your history matters before starting.
Systemic Hormone Therapy
If vaginal dryness is one of several symptoms you are managing, including hot flashes, disrupted sleep, or mood shifts, systemic hormone therapy addresses all of them at once. Systemic estrogen (with progesterone if you have a uterus) resolves GSM symptoms in most women while also targeting the broader hormonal picture.
For women who are appropriate candidates, systemic hormone therapy started within ten years of menopause has a well-documented safety and efficacy profile. Weighing this option works best with a thorough review of your personal and family health history with a physician who specializes in menopause care, because formulation and dose genuinely matter. WomenKind's hormone therapy for women program includes exactly that kind of detailed, individualized evaluation.
What to Expect From a Clinical Conversation
A good menopause specialist will not hand you a pamphlet and a tube of cream. They will ask about the nature and timing of your symptoms, your overall health history, whether you have had or are at elevated risk for hormone-sensitive conditions, what your sexual health goals are, and what you have already tried. This is a conversation that deserves more than a five-minute slot.
Because GSM symptoms often overlap with other midlife changes, a thorough provider will also consider whether urinary symptoms, recurrent infections, or discomfort during exercise are part of the picture. Lab work is sometimes useful for clarifying hormone levels, though symptoms, not numbers alone, drive treatment decisions. If you want a clearer sense of what lab testing can and cannot tell you in midlife, the post on preventive lab testing for midlife women covers that in depth.
Telehealth makes this kind of thorough evaluation accessible without requiring you to coordinate multiple in-person appointments. At WomenKind, the initial consultation is two hours, which allows enough time to actually review your history, discuss the evidence behind different treatment paths, and build a treatment plan that fits your life rather than a generic protocol. Unlimited messaging between appointments means follow-up questions do not have to wait for a scheduled slot. You can read more about what that process looks like on the sexual health care page.
Realistic Expectations and Long-Term Management
Treatment for GSM is not a short course. Because estrogen loss after menopause is permanent, ongoing treatment is generally what keeps symptoms managed. Most women using local estrogen or systemic hormone therapy find that symptoms are well-controlled as long as they continue treatment, and that stopping leads to a return of symptoms over months.
That said, long-term does not mean indefinite uncertainty. Regular check-ins with your provider allow you to adjust formulations, address any new symptoms, and make sure your treatment still fits your current health picture. Many women also find that as tissue health improves over the first several months of treatment, they regain sexual comfort they had quietly written off, which has its own meaningful effect on intimacy and daily confidence.
If you have been managing on your own for a while, or if a past provider dismissed what you were feeling as normal aging, it is worth getting a second opinion from a clinician who specializes in this area. The symptoms are common. The resignation does not have to be.
